Globeflex Capital’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,618
Closed -$408K 495
2023
Q2
$408K Hold
5,618
0.05% 271
2023
Q1
$428K Hold
5,618
0.05% 270
2022
Q4
$541K Hold
5,618
0.07% 244
2022
Q3
$634K Hold
5,618
0.11% 229
2022
Q2
$712K Buy
+5,618
New +$494K 0.17% 174

Other funds holding PRPH

Globeflex Capital's PRPH Position: Q3 2023 in Review

Globeflex Capital sold out of ProPhase Labs (PRPH) in Q3 2023, closing a stake of 5,618 shares — an estimated $408K sold.

Globeflex Capital first reported a position in PRPH in Q2 2022 and held it in 5 quarters. The position peaked at $712K in Q2 2022. 35 funds tracked by Wall St. Rank hold PRPH as of Q3 2023.

  • Globeflex Capital reported no remaining ProPhase Labs position as of Q3 2023 after selling out during the quarter.
  • Globeflex Capital sold 5,618 ProPhase Labs shares in Q3 2023, an estimated $408K.
  • Globeflex Capital first reported a position in ProPhase Labs in Q2 2022 and held it in 5 quarters.
  • Globeflex Capital's ProPhase Labs position peaked at $712K in Q2 2022.
  • 35 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2023.

Based on Globeflex Capital's 13F filing for Q3 2023, filed 13 Nov 2023.